QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
QQQ   309.88 (+2.07%)
AAPL   154.65 (+1.92%)
MSFT   267.56 (+4.20%)
META   191.62 (+2.99%)
GOOGL   107.64 (+4.61%)
AMZN   102.11 (-0.07%)
TSLA   196.81 (+1.05%)
NVDA   221.73 (+5.14%)
NIO   10.92 (-0.09%)
BABA   105.50 (+0.05%)
AMD   85.91 (+2.66%)
T   19.25 (-1.69%)
F   13.45 (+2.36%)
MU   62.13 (+3.58%)
CGC   2.82 (-4.41%)
GE   82.11 (-0.29%)
DIS   111.63 (+1.60%)
AMC   6.18 (-9.12%)
PFE   43.59 (-0.39%)
PYPL   83.23 (+1.09%)
NFLX   362.95 (+0.41%)
NASDAQ:ADUS

Addus HomeCare - ADUS Stock Forecast, Price & News

$106.31
+1.36 (+1.30%)
(As of 02/7/2023 12:00 AM ET)
Add
Compare
Today's Range
$103.28
$106.82
50-Day Range
$98.34
$112.55
52-Week Range
$68.57
$112.89
Volume
67,648 shs
Average Volume
70,690 shs
Market Capitalization
$1.71 billion
P/E Ratio
38.66
Dividend Yield
N/A
Price Target
$112.60

Addus HomeCare MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
5.9% Upside
$112.60 Price Target
Short Interest
Healthy
2.50% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.50
Upright™ Environmental Score
News Sentiment
1.06mentions of Addus HomeCare in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$3.05 M Sold Last Quarter
Proj. Earnings Growth
12.54%
From $3.11 to $3.50 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

260th out of 1,029 stocks

Home Health Care Services Industry

5th out of 9 stocks

ADUS stock logo

About Addus HomeCare (NASDAQ:ADUS) Stock

Addus HomeCare Corp. engages in the provision of in-home personal care services. It operates through the following segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, primarily to persons who are at risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The Hospice segment includes physical, emotional, and spiritual care for people who are terminally ill as well as for their families. The Home Health segment offers services that are primarily medical in nature to individuals who may require assistance during an illness or after surgery, and include skilled nursing and physical, occupational and speech therapy. The company was founded on July 27, 2006 and is headquartered in Frisco, TX.

Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

ADUS Stock News Headlines

A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Massive Insider Trade At Addus HomeCare
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
Addus HomeCare (ADUS) Tops Q3 Earnings Estimates
A Preview Of Addus HomeCare's Earnings
Addus HomeCare Announces Passing of Director Steven Geringer
Where Addus HomeCare Stands With Analysts
See More Headlines
Receive ADUS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Addus HomeCare and its competitors with MarketBeat's FREE daily newsletter.

ADUS Company Calendar

Last Earnings
10/31/2021
Today
2/07/2023
Next Earnings (Estimated)
2/23/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Home health care services
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:ADUS
Employees
31,915
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$112.60
High Stock Price Forecast
$130.00
Low Stock Price Forecast
$101.00
Forecasted Upside/Downside
+5.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
5 Analysts

Profitability

Net Income
$45.13 million
Pretax Margin
6.43%

Debt

Sales & Book Value

Annual Sales
$864.50 million
Cash Flow
$4.06 per share
Book Value
$36.06 per share

Miscellaneous

Free Float
15,385,000
Market Cap
$1.71 billion
Optionable
Optionable
Beta
0.83

Key Executives

  • R. Dirk AllisonR. Dirk Allison
    Chairman & Chief Executive Officer
  • W. Bradley BickhamW. Bradley Bickham
    President & Chief Operating Officer
  • Brian W. PoffBrian W. Poff
    CFO, Secretary, Treasurer & Executive VP
  • Nick Duthie
    Vice President-Information Technology
  • Michael WattenbargerMichael Wattenbarger
    Chief Information Officer & Executive VP













ADUS Stock - Frequently Asked Questions

Should I buy or sell Addus HomeCare stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Addus HomeCare in the last twelve months. There are currently 5 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" ADUS shares.
View ADUS analyst ratings
or view top-rated stocks.

What is Addus HomeCare's stock price forecast for 2023?

5 Wall Street analysts have issued 12-month price objectives for Addus HomeCare's shares. Their ADUS share price forecasts range from $101.00 to $130.00. On average, they predict the company's stock price to reach $112.60 in the next year. This suggests a possible upside of 6.5% from the stock's current price.
View analysts price targets for ADUS
or view top-rated stocks among Wall Street analysts.

How have ADUS shares performed in 2023?

Addus HomeCare's stock was trading at $99.49 on January 1st, 2023. Since then, ADUS shares have increased by 6.3% and is now trading at $105.72.
View the best growth stocks for 2023 here
.

When is Addus HomeCare's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, February 23rd 2023.
View our ADUS earnings forecast
.

How were Addus HomeCare's earnings last quarter?

Addus HomeCare Co. (NASDAQ:ADUS) released its quarterly earnings data on Sunday, October, 31st. The company reported $0.91 earnings per share for the quarter, beating the consensus estimate of $0.89 by $0.02. The company earned $216.66 million during the quarter, compared to the consensus estimate of $227.11 million. Addus HomeCare had a net margin of 4.77% and a trailing twelve-month return on equity of 8.46%. The company's quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.69 earnings per share.

What is Dirk Allison's approval rating as Addus HomeCare's CEO?

91 employees have rated Addus HomeCare Chief Executive Officer Dirk Allison on Glassdoor.com. Dirk Allison has an approval rating of 51% among the company's employees. This puts Dirk Allison in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Addus HomeCare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Addus HomeCare investors own include AbbVie (ABBV), Bank of America (BAC), Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Verizon Communications (VZ), CVS Health (CVS), Pfizer (PFE), Ulta Beauty (ULTA), Cisco Systems (CSCO) and Walt Disney (DIS).

What is Addus HomeCare's stock symbol?

Addus HomeCare trades on the NASDAQ under the ticker symbol "ADUS."

Who are Addus HomeCare's major shareholders?

Addus HomeCare's stock is owned by a number of institutional and retail investors. Top institutional investors include WCM Investment Management LLC (3.19%), Redwood Investments LLC (0.89%), Ziegler Capital Management LLC (0.72%), Tributary Capital Management LLC (0.70%), Allspring Global Investments Holdings LLC (0.37%) and Lisanti Capital Growth LLC (0.27%). Insiders that own company stock include Brian Poff, Darby Anderson, David W Tucker, Esteban Lopez, Laurie Manning, Mark L First, Michael D Wattenbarger, R Dirk Allison, Roberton James Stevenson, Sean Gaffney and W Bradley Bickham.
View institutional ownership trends
.

How do I buy shares of Addus HomeCare?

Shares of ADUS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Addus HomeCare's stock price today?

One share of ADUS stock can currently be purchased for approximately $105.72.

How much money does Addus HomeCare make?

Addus HomeCare (NASDAQ:ADUS) has a market capitalization of $1.70 billion and generates $864.50 million in revenue each year. The company earns $45.13 million in net income (profit) each year or $2.75 on an earnings per share basis.

How many employees does Addus HomeCare have?

The company employs 31,915 workers across the globe.

How can I contact Addus HomeCare?

Addus HomeCare's mailing address is 6801 GAYLORD PARKWAY, FRISCO TX, 75034. The official website for the company is www.addus.com. The company can be reached via phone at (469) 535-8200, via email at investorrelations@addus.com, or via fax at 630-487-2707.

This page (NASDAQ:ADUS) was last updated on 2/7/2023 by MarketBeat.com Staff